Next Article in Journal
Epidemiology of Musculoskeletal Injuries in Adult Athletes: A Scoping Review
Previous Article in Journal
The Change of Lumbar Spinal Stenosis Symptoms over a Six-Year Period in Community-Dwelling People
Previous Article in Special Issue
Using an Electromyography Method While Measuring Oxygen Uptake to Appreciate Physical Exercise Intensity in Adolescent Cyclists: An Analytical Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparison and Performance Validation of Calculated and Established Anaerobic Lactate Thresholds in Running

1
The German Research Centre of Elite Sport, German Sport University Cologne, 50933 Cologne, Germany
2
Department of Sports Medicine and Exercise Physiology, Institute of Sport Sciences, Goethe University Frankfurt, 60487 Frankfurt, Germany
3
Department of Molecular and Cellular Sport Medicine, Institute of Cardiology and Sports Medicine, German Sport University Cologne, 50933 Cologne, Germany
4
Institute of Interdisciplinary Exercise Science and Sports Medicine, Medical School Hamburg, 20457 Hamburg, Germany
*
Author to whom correspondence should be addressed.
Medicina 2021, 57(10), 1117; https://doi.org/10.3390/medicina57101117
Submission received: 15 September 2021 / Revised: 4 October 2021 / Accepted: 12 October 2021 / Published: 16 October 2021
(This article belongs to the Special Issue Muscle and Exercise Physiology)

Abstract

:
Background and Objectives: This study aimed to compare the calculated running velocity at the anaerobic lactate threshold (cLTAn), determined by a mathematical model for metabolic simulation, with two established threshold concepts (onset of blood lactate accumulation (OBLA; 4 mmol∙L−1) and modified maximal deviation method (mDmax)). Additionally, all threshold concepts were correlated with performance in different endurance running events. Materials and Methods: Ten sub-elite runners performed a 30 s sprint test on a cycle ergometer adjusted to an isokinetic mode set to a cadence of 120 rpm to determine maximal lactate production rate (VLamax), and a graded exercise test on a treadmill to determine maximal oxygen uptake (VO2max). Running velocities at OBLA, mDmax, and cLTAn were then compared with each other, and further correlated with running performance over various distances (3000 m, 5000 m, and 10,000 m). Results: The mean difference in cLTAn was −0.13 ± 0.43 m∙s−1 and −0.32 ± 0.39 m∙s−1 compared to mDmax (p = 0.49) and OBLA (p < 0.01), respectively. cLTAn indicated moderate to good concordance with the established threshold concepts (mDmax: ICC = 0.87, OBLA: ICC = 0.74). In comparison with other threshold concepts, cLTAn exhibited comparable correlations with the assessed running performances (cLTAn: r = 0.61–0.76, mDmax: r = 0.69–0.79, OBLA: r = 0.56–0.69). Conclusion: Our data show that cLTAn can be applied for determining endurance performance during running. Due to the consideration of individual physiological profiles, cLTAn offers a physiologically justified approach to assess an athlete’s endurance performance.

1. Introduction

Determination of the blood lactate response during exercise is among the most widely used performance diagnostic tools [1,2]. Blood lactate concentration increases above the resting value with increasing exercise intensity. However, as long as exercise is performed at a constant exercise intensity under a certain intensity threshold, blood lactate concentration remains constant, physiologically known as a steady-state condition [3,4]. At a certain exercise intensity, a minor increment in the workload induces an accelerated blood lactate accumulation and subsequent fatigue-related metabolic consequences, such as the negative impact of hydrogen ion accumulation (acidosis) on muscle function and performance [4,5,6,7]. This considerable point has been defined as the anaerobic lactate threshold (LTAn), which is generally considered to be a good indicator of individual aerobic endurance performance and can be used for prescribing endurance training intensities [8,9].
In recent decades, researchers have developed several concepts to determine LTAn. Most LTAn concepts are usually applied to lactate performance curves derived from graded incremental exercise tests [8]. Most existing LTAn concepts use either fixed lactate concentrations [4,10] or inflection points [11,12] as their determination criteria. However, these criteria are derived either arbitrarily or empirically from the graphical analysis of the lactate performance curve. Moreover, LTAn has shown to be strongly dependent on the applied test protocol [13,14] and on the athlete’s training status [15], which is critical because there is no clear standardized test procedure defined, which thus hinders accurate data interpretation and comparison. Therefore, the physiological background and the validity/reliability/comparability of these LTAn concepts have been questioned [8].
Lactate production and removal are ongoing processes, which are closely related to metabolic rate but not necessarily to oxygen delivery [5,6,16,17]. There is a continual exchange of lactate between various organs and cells, which can be used as an energy source for oxidative energy production and/or as a major precursor to gluconeogenesis [5,17]. This emphasizes the complexity of metabolic processes behind blood lactate concentrations during exercise or other conditions. Limiting interpretation solely to blood lactate kinetics in response to graded exercise tests allows only scarce insight into the complex metabolic processes of total energy production [18,19].
In 1984, Mader [20] suggested that the lactate performance curve and the corresponding exercise intensity at LTAn may be influenced by aerobic (maximal oxygen uptake; VO2max) or anaerobic (glycolytic) capacity (maximal lactate production rate; VLamax) separately [20]. Further research confirmed this assumption and showed that different combinations of VO2max and VLamax can result in two identical lactate performance curves with equal LTAn [18]. In a more differentiated approach, Mader and Heck [3] proposed a mathematical simulation model of energy production processes in skeletal muscle. Using Michaelis–Menten kinetics, these researchers described the activation of glycolysis as a lactate production system and the oxidative phosphorylation as a combustion system, both depending on the total metabolic rate [3]. Based on this theoretical construct, the term “maximal steady-state of blood lactate (MLSS)” was introduced (as another concept of LTAn), at which the extent of lactate formation by glycolysis is exactly equal to the maximal elimination rate of lactate by combustion. Thus, no lactate accumulation in blood lactate over time occurs (Figure 1) [3]. Thereby, it was suggested that accelerated accumulation of blood lactate during exercise is due to the saturation of the combustion system (oxidative phosphorylation) [3], which was later verified by subsequent investigations of lactate kinetics during exercise [6,21]. As this mathematical model considers both the maximal aerobic and anaerobic capacities for the determination of LTAn, it provides differentiated information about the energetic background of LTAn, as well as the physiological profile of an athlete [18].
Based on Mader’s approach, Hauser et al. [22] applied the mathematical model to calculate the power output at MLSS during cycling using individual VO2max- and VLamax-values and demonstrated a significant correlation with the experimental determined MLSS, and high reliability in the estimation of MLSS [23]. However, there is a lack of knowledge regarding the transferability of the model to running. Furthermore, the calculation method in the previous study [22] has only been compared to the empirically determined MLSS, but not to the actual athlete’s competition performance, which is an essential aspect for a practical application of a laboratory testing parameter [8]. Therefore, this study aimed to calculate running velocity at LTAn using individual VO2max and VLamax and an adapted mathematical method initially described by Mader and Heck [3] and Hauser et al. [22]. The calculated LTAn (cLTAn) was then compared with other established experimentally determined LTAn concepts. Additionally, we aimed to validate cLTAn against the athlete’s recent performance in endurance running events.

2. Materials and Methods

2.1. Subjects

Ten sub-elite male middle- and long-distance runners (age = 19.2 ± 3.5 years, body mass = 65.8 ± 5.8 kg, height = 181.7 ± 5.2 cm, VO2max = 69.8 ± 6.7 mL∙kg−1 min−1, VLamax = 0.39 ± 0.09 mmol L−1 s−1) participated in this study. Prior to signing the written informed consent of the investigation, all participants were informed about the experimental procedures. The protocols used in this investigation were approved by the Ethics Committee of the university and are in line with the Declaration of Helsinki.

2.2. Design

The present investigation consisted of two different performance tests completed on a single day. The body mass was measured before the performance testing (Tanita Corp., Tokyo, Japan). Participants were instructed to arrive in the laboratory in a rested, 2 h postprandial, and well-hydrated state. They were ordered to avoid strenuous exercise for at least 24 h before the test.
First, the participants performed a 30 s isokinetic sprint test on a cycle ergometer with subsequent measurements of whole-blood lactate concentration for the determination of VLamax. After a 60 min break, a graded exercise test on a treadmill (second test) was performed to determine VO2max and running velocity at the onset of blood lactate accumulation (OBLA; 4 mmol∙L−1) [4] and at the modified maximal deviation point (mDmax) [24]. The cLTAn was determined according to the calculation scheme described by Mader and Heck [3], as well as by Hauser et al. [22], and subsequently compared with OBLA and mDmax. To evaluate the validity of cLTAn, OBLA, and mDmax as indicators of endurance performance, running velocities at each concept were compared with the participant’s performance (average velocity (m·s−1)) over various distances (3000 m, 5000 m, and 10,000 m). One participant did not provide performance data, so only data from nine participants were included in correlation analysis.

2.3. Isokinetic Sprint Test and VLamax Determination (Performance Capacity of Glycolysis)

The participants first performed a 10 min standardized warm-up at 1.5 W kg−1 body mass. After an additional passive rest for 5 min, a 30 s sprint test was performed on a cycle ergometer adjusted to an isokinetic mode set to a cadence of 120 rpm [25,26]. Participants were instructed to perform the test in a sitting position and were verbally encouraged throughout the test to achieve and maintain maximal effort. After the sprint, participants took a rest in a sitting position for 10 min. Immediately before sprint testing, as well as every minute after the sprint bout (1′–10′), 20 μL of capillary blood was taken from the earlobe for lactate analysis (Biosen C-line; EKF Diagnostic Sales, Magdeburg, Germany). The VLamax was calculated using the following equation [27]:
VLamax (mmol L−1 s−1) = ([La]peak − [La]rest) ∙ (texerctalac)−1
where Lapeak (mmol L−1) is the peak post-exercise lactate concentration, Larest (mmol L−1) is the resting lactate concentration, texerc (s) is the duration of exercise, and talac (s) is the period at the beginning of exercise in which no lactate formation is assumed. According to Heck et al. [27], talac was set to 5.5 s for all participants.

2.4. Graded Exercise Running Test and VO2max and LTAn Determination

The graded exercise test was performed on a treadmill (Woodway, Weil am Rhein, Germany), which started at 2.4 m s−1 and increased by 0.4 m s−1 every 5 min until volitional exhaustion was reached. After each step of the graded exercise test, a 30 s rest was given for blood sampling. Furthermore, heart rate (HR) (H7, Polar Electro Oy, Kempele, Finland) and breath-by-breath expired gases (Cortex Metalyzer II, Leipzig, Germany) were continuously measured throughout the test. The VO2max corresponded to the highest value measured (moving average of 30 s) during the test.
Blood lactate concentrations during the incremental tests were plotted against running velocity and then fitted by a third-order polynomial function. Running velocity at OBLA was set as the point at which blood lactate concentration reached 4 mmol∙L−1 [4]. mDmax was identified as the point on the third-order polynomial curve that yielded the maximal perpendicular distance to a straight line formed by the peak lactate point, and by the point of the first rise in blood lactate concentration at which the slope of the fitted lactate curve was equal to 1.00 [24].

2.5. Calculation of Running Velocity at cLTAn

To determine cLTAn, the oxidative and glycolytic energy production depending on exercise intensity must initially be known, which can be expressed as the activity of oxidative phosphorylation (VO2ss) and glycolysis (VLass), respectively [3]. The theoretical background of the applied equations and constants is explained in detail by previous publications [3,22].
According to Mader and Heck [3], the implementation of the metabolic simulation model requires knowing the free ADP concentration, which is the main regulating substrate for the activation of VO2ss and VLass. Since there is no simple and practical procedure for measuring free ADP concentration, the ADP-dependent equations in the previous study were transposed into VO2ss-dependent equations [22]. On this occasion, the term “VO2ss” represents the steady-state oxygen consumption at a constant work rate [3,22]. Hauser et al. [22] calculated the VO2ss in relation to exercise intensity based on the assumption of a linear relationship between oxygen demand (VO2) and workload. Thereby, a constant value for VO2 per 1 W (Ks4 = 11.7 mL O2 W−1) was used for all participants based on the data of previous cycling experiments [3,28]. However, it should be noted that VO2 in running is more affected by an athlete’s exercise economy (i.e., metabolic cost at a given workload) than in cycling. Running economy was shown to be influenced by several physiological and biomechanical factors [29], which can lead to greater inter-individual variation in comparison to the cycling economy due to weight-bearing activity [30]. Therefore, it is necessary to determine Ks4 (mL kg−1·min−1 per 1 m∙s−1 running velocity) individually, by plotting VO2 during incremental tests against running velocity. The Ks4 corresponded to the slope of linear regression (y = mx + b) between VO2 and running speed (Figure 2).
After determining the individual Ks4, the VO2ss in relation to running velocity was calculated with Equation (2).
VO2ss (mL kg−1 min−1) = V Ks4 + VO2rest
where v (m s−1) is the running velocity, VO2rest (mL kg−1 min−1) is the resting oxygen uptake, and Ks4 is the constant value of the relationship between oxygen demand and the running velocity (i.e., mL kg−1 per 1 m s−1 running velocity).
By knowing VO2ss (from resting level to VO2max), it is possible to calculate VLass (lactate formation) as a function of VO2ss, as demonstrated in the following equation:
VLa ss   ( mmol   L 1   min 1 ) = 60   ·   V ˙ L a m a x 1 + ( Ks 2 Ks 1 · V ˙ O 2 ss V ˙ O 2 max V ˙ O 2 ss 3 )
where VLamax (mmol L−1·s−1) is the maximal glycolytic rate, VO2max (mL kg−1 min−1) is the maximal oxygen uptake, VO2ss (mL kg−1 min−1) is the steady-state oxygen consumption, and Ks1 and Ks2 are the 50% activity rate constant of oxidative phosphorylation (0.0631) and glycolysis (1.331), respectively [22].
Furthermore, the maximal lactate elimination rate (VLaoxmax) which depends on VO2ss can also be calculated based on the experimentally estimated value of lactate equivalent (i.e., the amount of oxidized lactate per unit O2), lactate distribution volume [3], and using the following equation:
VLa oxmax   ( mmol   L 1   min 1 ) = lactate-equivalent lactate   distribution   volume   · VO 2 s s = 0.02049 0.4 · VO 2 s s
where VLaoxmax (mmol L−1 min−1) is the maximal lactate elimination rate as a function of the steady-state oxygen consumption (VO2ss; mL kg−1 min−1) [22].
According to Hauser et al. [22], lactate-equivalent and lactate distribution volume were set to 0.02049 mmol lactate per 1 mL O2 and 0.4 L H2O per kg body weight, respectively. Thus, simulating the simultaneous lactate formation and elimination depending on the metabolic rate or running speed can be carried out based on the individual VO2max and VLamax value, as well as body weight. cLTAn is defined as the running velocity at which the lactate formation is exactly equal to elimination (i.e., VLass = VLaoxmax).

2.6. Statistical Analysis

For statistical analysis of the data, the software IBM SPSS version 24 (Chicago, IL, USA) was used. Descriptive statistics of the data are presented as means ± standard deviation (±SD). The normal distribution and the variance homogeneity were verified using the Shapiro–Wilk test and Mauchly test of sphericity, respectively. Statistically relevant differences between the three LTAn concepts were determined using one-way repeated measure ANOVA with Bonferroni correction for post hoc tests. Statistical differences were considered to be significant for p ≤ 0.05. To estimate the practical relevance, effect sizes (partial eta squared, ηp²) were calculated for the main effect. According to Cohen [31], a ηp² ≥ 0.01 indicates small effects, ≥0.059 medium effects, and ≥0.138 large effects. To display the concordance between the LTAn concepts, Bland–Altman plots were constructed. Furthermore, the intra-class correlation coefficients (ICC) were calculated based on a single-measure two-way mixed-effects model. For evaluating the degree of agreement between cLTAn vs. OBLA or mDmax, the “absolute agreement” type of analysis (ICC (2,1)) was chosen. For the comparison of each LTAn concept vs. 3000 m, 5000 m, or 10,000 m, we chose the “consistency” type of analysis (ICC (3,1)). According to Koo and Li [32], the degree of agreement was interpreted as follows: <0.50 = poor, 0.50–0.75 = moderate, 0.75–0.90 = good, and >0.90 = excellent. Pearson’s correlations were also calculated and interpreted as follows: 0.0–0.3 = negligible, 0.3–0.5 = low, 0.5–0.7 = moderate, 0.7–0.9 = high, and 0.9–1.0 = very high [33].

3. Results

Individual values of maximal metabolic performance tests and individual running velocities at each LTAn concept are presented in Table 1.
Repeated measures ANOVA showed a significant difference between LTAn concepts with a large effect (p < 0.01, η2p = 0.63). Post hoc analysis using Bonferroni correction revealed that running velocity at OBLA was significantly higher compared to cLTAn and mDmax (p < 0.01). No significant difference was found between running velocity at cLTAn and mDmax (p = 0.49). The cLTAn indicated a high correlation with OBLA (r = 0.83, r2 = 0.70, p < 0.01) and mDmax (r = 0.81, r2 = 0.65, p < 0.01). Between OBLA and mDmax, there was a very high correlation (r = 0.94, r2 = 0.89, p < 0.001).
According to the Bland–Altman Plots (Figure 3), the mean difference in cLTAn was −0.13 ± 0.43 m∙s−1 and −0.32 ± 0.39 m∙s−1 compared to mDmax and OBLA, respectively. The intraclass correlation coefficient comparing cLTAn with mDmax showed a good agreement (ICC = 0.87), whereas a moderate agreement was shown between cLTAn and OBLA (ICC = 0.74).
The mean running velocities over the distances of 3000 m, 5000 m, and 10,000 m were 5.65 ± 0.29 m s−1, 5.37 ± 0.26 m s−1, and 5.03 ± 0.26 m s−1, respectively. cLTAn and mDmax indicated moderate to high correlations with running performance over all distances observed (cLTAn: 0.61 < r < 0.76, 0.37 < r2 < 0.58, p < 0.05; mDmax: 0.69 < r < 0.79, 0.48 < r2 < 0.62, p < 0.05), whereby OBLA had the poorest correlations (0.56 < r < 0.69, 0.32 < r2 < 0.48, p ≤ 0.09) compared to other concepts in most cases (Figure 4a). The intraclass correlation (Figure 4b) also revealed good concordance of cLTAn (ICC = 0.75–0.86) and mDmax (ICC = 0.82–0.88) with running performance over all distances observed, whereas OBLA showed only moderate concordance (ICC = 0.68–0.80) in most cases.

4. Discussion

The purpose of this study was to determine cLTAn in running by adapting the mathematical model for metabolic simulation previously described by Mader and Heck [3] and Hauser et al. [22]. cLTAn demonstrated moderate to good concordance with the established concepts in determining the running velocity at LTAn. Although cLTAn provided lower running velocity compared to mDmax and OBLA, the correlation of cLTAn with the endurance running performance was similar compared to mDmax and even better compared to OBLA.
One of the relevant criteria for the practical application of a laboratory test parameter is its relationship with competitive performance. A comprehensive review by Faude et al. [8] demonstrated moderate to high correlations (r = 0.66–0.92) between various LTAn concepts and performance in endurance running competitions and therefore justified the practical application of those concepts in sports diagnostics. Even though cLTAn did not indicate significantly superior results, its good concordance (ICC = 0.75–0.86) with mDmax and OBLA, as well as comparable correlations (r = 0.61–0.76) with competition performance, can support its applicability as a valid indicator to assess an athlete’s endurance performance.
The metabolic simulation model (cLTAn) incorporates the influence of individual VO2max, VLamax, and Ks4 on LTAn, as well as their combined effects [18,22]. This could enable a more differentiated approach in the interpretation of the endurance performance of an athlete. The individually determined Ks4 values are dependent on individual exercise economy, expressed by the relationship between energy demand and running velocity [29]. Especially in well-trained athletes with similar VO2max, running economy has been shown to be a crucial indicator of distance running performance [29,34,35]. The consideration of individual physiological profiles allows specific explanations of how equal and/or different endurance performance can be achieved regarding the interplay of single metabolic parameters [18]. For instance, participants 3 and 7 in our study showed similar aerobic and anaerobic capacities (VO2max: 80.3 vs. 80.1 mL kg−1∙min−1, VLamax: 0.33 vs. 0.31 mmol L−1 s−1); however, participant 3 displayed a much higher speed at LTAn regardless of the used LTAn concept (Table 1) and, consequently, better performance compared to participant 7 (e.g., 10,000 m running time: 30 vs. 32 min). In this case, the performance differences could be explained by much lower Ks4 (13.2 vs. 14.2 mL kg−1 min−1 per 1 m s−1). A recent training study used the metabolic simulation-model-detected training-induced changes in single performance capacities (i.e., VO2max and VLamax). The authors reported specific explanations of changes in endurance performance (MLSS) [36], which highlights the potential for the practical application of the model.
Despite the moderate to good agreement with other LTAn concepts, cLTAn systematically provides lower running velocities in our study (Figure 3). This discrepancy could be attributed to the underrated VO2max by using a graded exercise test. The main reason we used a graded incremental protocol, instead of a ramp protocol, was to concurrently determine OBLA and mDmax, as well as the relationship between steady-state oxygen demand and running velocity (i.e., individual Ks4). However, the mean time to exhaustion of our test protocol was ~38 min, which is significantly longer than the “optimal” test duration for assessing VO2max, as suggested by previous studies [37,38,39]. Sperlich et al. [40] reported that VO2max, achieved with the same graded exercise test protocol as in our study, was significantly lower (on average 2 mL min−1 kg−1) than assessed by incremental tests with shorter test duration (ranged from 7–11 min). Hauser [28] showed that a theoretical 25% increase in VO2max (and constant VLamax, and Ks4) leads to a 44% increase in calculated MLSS in cycling. Indeed, cLTAn is increased by ~0.2 m s−1 when the participant’s VO2max is increased by 2 mL min−1 kg−1 (and constant values of VLamax, and Ks4), and thus the difference between running speed at cLTAn and the other LTAn is reduced (data not presented). To solve the underestimation of VO2max, further work should use a VO2max verification bout [41,42] or a combined step- and ramp-exercise protocol [43]. Such protocols could ensure the appropriate determination of VO2max and the individual Ks4 at the same time, as two core parameters of the metabolic simulation model.
Another potential contributing factor to the difference between cLTAn and other LTAn concepts could be the run-nonspecific test procedure for the assessment of VLamax and its influence on cLTAn. The cycling sprint test is an established anaerobic test for nearly all sports disciplines. Thus, we determined the participant’s VLamax using an isokinetic cycle sprint [22,23,36,44]. However, the peak post-exercise lactate concentration, which is a key parameter for the estimation of VLamax, is dependent on the exercise modality used in tests [44]. Unfortunately, up to now no established running-specific test procedure for VLamax determination exists. Just recently, Quittmann et al. [45] attempted to measure VLamax and sprint performance parameters using a running sprint test. However, this study used fixed distances, rather than a fixed time for the sprint test, which might influence VLamax determination. Whether and how VLamax estimation and cLTAn determination would be affected by applying a running-specific anaerobic test procedure remain to be clarified.
Since VO2ss contributes as a core parameter to the calculation of both the lactate formation and elimination rate at any given running velocity, it is necessary to determine VO2ss (from resting level to VO2max) as precisely as possible. For the determination of VO2ss, the relationship between oxygen demand and running velocity (Ks4) plays an important role [3]. In contrast to the previous study in cycling [22], we individually determined the Ks4 value considering the inter-individual variation in the running economy. Typically, it is assumed that there is a linear relationship between VO2 and workload. This has been supported by several investigations indicating a nearly invariant oxygen cost of transport (calculated by dividing oxygen uptake by running velocity, mL kg−1 km−1) over a range of running speeds (2.0–4.0 m s−1) [46,47]. However, these studies investigated the individual running energetics only from the start of exercise until LTAn intensity and not till exhaustion. Daniels and Daniels [48] suggested that the metabolic demand of running is not exclusively dependent on running speed and can vary with an athlete’s specialized background. They found that most of the 800–1500 m specialists in their study showed an equal oxygen cost of transport over all intensities examined. In contrast to that, the specialists in longer distances (3000 m—marathon) mostly showed an increased oxygen cost of transport at exercise intensities above 70% of VO2max [48]. These findings emphasize the importance of considering the individual running energetics over all possible test speeds to assess the performance difference between athletes. To what extent the running energetics, especially near the LTAn intensity, differ between athletes, and how they affect the LTAn, is unclear. With respect to the previous model in cycling [22], we, therefore, decided to use the Ks4 from a linear fit to calculate VO2ss in our study. However, there is abundant space for further progress in analyzing the relationship between metabolic rate and running velocity and its influence on cLTAn determination. For instance, a curvilinear fit suggested by Batliner et al. [49] might better assess the inter-individual difference in running energetics, especially around and above the LTAn intensity, which might consequently lead to an improved performance prediction of cLTAn.
In addition to the above methodological limitations, it is important to note that our data did not address the basic variability and reproducibility of each physiological measure (VO2max, VLamax, and Ks4), which are also relevant quality criteria for the application of the cLTAn. However, previous research in cycling already demonstrated a very high reliability for both VO2max and VLamax, as well as the calculated MLSS from these two parameters [23]. Further studies with a longitudinal analysis in running should be carried out to investigate the reliability and sensitivity of the single performance tests and metabolic simulation model for detecting performance changes.

5. Practical Applications

The present study suggests that the mathematical model for metabolic simulation could be applied to assess an athlete’s endurance performance in running by considering multiple physiological parameters. Considering multiple physiological measures, the metabolic simulation model (cLTAn) provides an insight into the complex interplay of single metabolic systems and their influence on endurance performance. This allows a differentiated interpretation of the athlete’s performance, which could be useful for establishing training interventions targeting and eliminating specific weaknesses in the physiological profile of an athlete.

6. Conclusions

The metabolic simulation model considers different metabolic parameters to evaluate an athlete’s performance profile. In determining running velocity at LTAn, the metabolic simulation model (cLTAn) revealed a moderate to good agreement with other established concepts. However, the velocity at cLTAn was lower with regard to the other LTAn concepts. With regard to the compared LTAn concepts, comparable and partially better correlations between cLTan and the endurance performance of sub-elite middle- and long-distance runners were found.

Author Contributions

Conceptualization, P.W.; methodology, S.J., A.S. and P.W.; formal analysis, S.J.; investigation, S.J., A.S. and P.W.; resources, P.W. and W.B.; data curation, S.J., A.S. and P.W.; writing—original draft preparation, S.J.; writing—review and editing, S.J., A.S. and P.W.; visualization, S.J.; supervision, P.W. and W.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of German Sport University Cologne (approval code: 146/2021; approval date: 4 October 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Billat, V.L. Use of Blood Lactate Measurements for Prediction of Exercise Performance and for Control of Training. Recommendations for Long-Distance Running. Sports Med. 1996, 22, 157–175. [Google Scholar] [CrossRef]
  2. Jacobs, I. Blood Lactate. Sports Med. 1986, 3, 10–25. [Google Scholar] [CrossRef]
  3. Mader, A.; Heck, H. A Theory of the Metabolic Origin of “Anaerobic Threshold”. Int. J. Sports Med. 1986, 7, 45–65. [Google Scholar] [CrossRef]
  4. Heck, H.; Mader, A.; Hess, G.; Mücke, S.; Müller, R.; Hollmann, W. Justification of the 4-Mmol/l Lactate Threshold. Int. J. Sports Med. 1985, 6, 117–130. [Google Scholar] [CrossRef] [PubMed]
  5. Brooks, G.A. Lactate glycolytic end product and oxidative substrate during sustained exercise in mammals—The “lactate shuttle”. In Circulation, Respiration, and Metabolism; Springer: Berlin/Heidelberg, Germany, 1985; pp. 208–218. [Google Scholar]
  6. Messonnier, L.A.; Emhoff, C.A.W.; Fattor, J.A.; Horning, M.A.; Carlson, T.J.; Brooks, G.A. Lactate Kinetics at the Lactate Threshold in Trained and Untrained Men. J. Appl. Physiol. 2013, 114, 1593–1602. [Google Scholar] [CrossRef] [PubMed]
  7. Hering, G.O.; Hennig, E.M.; Riehle, H.J.; Stepan, J. A Lactate Kinetics Method for Assessing the Maximal Lactate Steady State Workload. Front. Physiol. 2018, 9, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Faude, O.; Kindermann, W.; Meyer, T. Lactate Threshold Concepts: How Valid Are They? Sports Med. 2009, 39, 469–490. [Google Scholar] [CrossRef]
  9. Svedahl, K.; MacIntosh, B.R. Anaerobic Threshold: The Concept and Methods of Measurement. Can. J. Appl. Physiol. 2003, 28, 299–323. [Google Scholar] [CrossRef] [Green Version]
  10. Kindermann, W.; Simon, G.; Keul, J. The Significance of the Aerobic-Anaerobic Transition for the Determination of Work Load Intensities during Endurance Training. Eur. J. Appl. Physiol. Occup. Physiol. 1979, 42, 25–34. [Google Scholar] [CrossRef]
  11. Cheng, B.; Kuipers, H.; Snyder, A.C.; Keizer, H.A.; Jeukendrup, A.; Hesselink, M. A New Approach for the Determination of Ventilatory and Lactate Thresholds. Int. J. Sports Med. 1992, 13, 518–522. [Google Scholar] [CrossRef]
  12. Bishop, D.; Jenkins, D.G.; Mackinnon, L.T. The Relationship between Plasma Lactate Parameters, Wpeak and 1-h Cycling Performance in Women. Med. Sci. Sports Exerc. 1998, 30, 1270–1275. [Google Scholar] [CrossRef] [PubMed]
  13. Riboli, A.; Rampichini, S.; Cè, E.; Limonta, E.; Coratella, G.; Esposito, F. Effect of Ramp Slope on Different Methods to Determine Lactate Threshold in Semi-Professional Soccer Players. Res. Sports Med. 2019, 27, 326–338. [Google Scholar] [CrossRef] [PubMed]
  14. Jamnick, N.A.; Botella, J.; Pyne, D.B.; Bishop, D.J. Manipulating Graded Exercise Test Variables Affects the Validity of the Lactate Threshold and VO2peak. PLoS ONE 2018, 13, e0199794. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Riboli, A.; Rampichini, S.; Cè, E.; Limonta, E.; Borrelli, M.; Coratella, G.; Esposito, F. Training Status Affects between-Protocols Differences in the Assessment of Maximal Aerobic Velocity. Eur. J. Appl. Physiol. 2021, 121, 3083–3093. [Google Scholar] [CrossRef] [PubMed]
  16. Gladden, L.B. Lactate Metabolism: A New Paradigm for the Third Millennium. J. Physiol. 2004, 558, 5–30. [Google Scholar] [CrossRef]
  17. Brooks, G.A. The Science and Translation of Lactate Shuttle Theory. Cell Metab. 2018, 27, 757–785. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Bleicher, A.; Mader, A.; Mester, J. Zur Interpretation von Laktatleistungskurven—Experimentelle Ergebnisse Mit Computergestützten Nachber. Spectr. Sportwiss. 1998, 10, 92–104. [Google Scholar]
  19. Olbrecht, J. Lactate production and metabolism in swimming. In World Book of Swimming. From Science to Performance; Nova: New York, NY, USA, 2011; pp. 255–276. [Google Scholar]
  20. Mader, A. Eine Theorie zur Berechnung der Dynamik und des Steady State von Phosphorylierungszustand und Stoffwechselaktivität der Muskelzelle Als Folge des Energiebedarfs; Deutsche Sporthochschule Köln: Köln, Germany, 1984. [Google Scholar]
  21. Stainsby, W.N.; Brooks, G.A. Control of Lactic Acid Metabolism in Contracting Muscles and during Exercise. Exerc. Sport Sci. Rev. 1990, 18, 29–64. [Google Scholar] [CrossRef]
  22. Hauser, T.; Adam, J.; Schulz, H. Comparison of Calculated and Experimental Power in Maximal Lactate-Steady State during Cycling. Theor. Biol. Med. Model. 2014, 11, 1–12. [Google Scholar] [CrossRef] [Green Version]
  23. Adam, J.; Öhmichen, M.; Öhmichen, E.; Rother, J.; Müller, U.M.; Hauser, T.; Schulz, H. Reliability of the Calculated Maximal Lactate Steady State in Amateur Cyclists. Biol. Sport 2015, 32, 97–102. [Google Scholar] [CrossRef]
  24. Zwingmann, L.; Strütt, S.; Martin, A.; Volmary, P.; Bloch, W.; Wahl, P. Modifications of the Dmax Method in Comparison to the Maximal Lactate Steady State in Young Male Athletes. Physician Sportsmed. 2019, 47, 174–181. [Google Scholar] [CrossRef] [PubMed]
  25. Faria, E.W.; Parker, D.L.; Faria, I.E. The Science of Cycling Physiology and Training-Part 1. Sports Med. 2005, 35, 285–312. [Google Scholar] [CrossRef] [PubMed]
  26. Wahl, P.; Zinner, C.; Grosskopf, C.; Rossmann, R.; Bloch, W.; Mester, J. Passive Recovery Is Superior to Active Recovery during a High-Intensity Shock Microcycle. J. Strength Cond. Res. 2013, 27, 1384–1393. [Google Scholar] [CrossRef] [PubMed]
  27. Heck, H.; Schulz, H.; Bartmus, U. Diagnostics of Anaerobic Power and Capacity. Eur. J. Sport Sci. 2003, 3, 1–23. [Google Scholar] [CrossRef]
  28. Hauser, T. Untersuchungen zur Validität und Praktikabilität des Mathematisch Bestimmten Maximalen Laktat-Steady-States Bei Radergometrischen Belastungen; Chemnitz University of Technology: Chemnitz, Germany, 2013. [Google Scholar]
  29. Saunders, P.U.; Pyne, D.B.; Telford, R.D.; Hawley, J.A. Factors Affecting Running Economy in Trained Distance Runners. Sports Med. 2004, 34, 465–485. [Google Scholar] [CrossRef] [PubMed]
  30. Swinnen, W.; Kipp, S.; Kram, R. Comparison of Running and Cycling Economy in Runners, Cyclists, and Triathletes. Eur. J. Appl. Physiol. 2018, 118, 1331–1338. [Google Scholar] [CrossRef]
  31. Cohen, J. Statistical Power Analysis for the Behavioral Sciences; Taylor and Francis: Hoboken, NJ, USA, 1988. [Google Scholar]
  32. Koo, T.K.; Li, M.Y. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J. Chiropr. Med. 2016, 15, 155–163. [Google Scholar] [CrossRef] [Green Version]
  33. Mukaka, M.M. A Guide to Appropriate Use of Correlation Coefficient in Medical Research. Malawi Med. J. 2012, 24, 69–71. [Google Scholar]
  34. Barnes, K.R.; Kilding, A.E. Running Economy: Measurement, Norms, and Determining Factors. Sports Med.-Open 2015, 1, 1–15. [Google Scholar] [CrossRef] [Green Version]
  35. Morgan, D.; Baldini, F.; Martin, P.; Kohrt, W. Ten Kilometer Performance and Predicted Velocity at VO2max among Well-Trained Male Runners. Med. Sci. Sports Exerc. 1989, 21, 78–83. [Google Scholar] [CrossRef]
  36. Hommel, J.; Öhmichen, S.; Rudolph, U.M.; Hauser, T.; Schulz, H. Effects of Six-Week Sprint Interval or Endurance Training on Calculated Power in Maximal Lactate Steady State. Biol. Sport 2019, 36, 47–54. [Google Scholar] [CrossRef] [PubMed]
  37. Buchfuhrer, M.J.; Hansen, J.E.; Robinson, T.E.; Sue, D.Y.; Wasserman, K.; Whipp, B.J. Optimizing the Exercise Protocol for Cardiopulmonary Assessment. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 1983, 55, 1558–1564. [Google Scholar] [CrossRef]
  38. González-Alonso, J.; Calbet, J.A.L. Reductions in Systemic and Skeletal Muscle Blood Flow and Oxygen Delivery Limit Maximal Aerobic Capacity in Humans. Circulation 2003, 107, 824–830. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Bentley, D.J.; Newell, J.; Bishop, D. Incremental Exercise Test Design and Analysis: Implications for Performance Diagnostics in Endurance Athletes. Sports Med. 2007, 37, 575–586. [Google Scholar] [CrossRef] [PubMed]
  40. Sperlich, P.F.; Holmberg, H.-C.; Reed, J.L.; Zinner, C.; Mester, J.; Sperlich, B. Individual versus Standardized Running Protocols in the Determination of VO2max. J. Sports Sci. Med. 2015, 14, 386. [Google Scholar] [PubMed]
  41. Poole, D.C.; Jones, A.M. Measurement of the Maximum Oxygen Uptake VO2max: VO2peak Is No Longer Acceptable. J. Appl. Physiol. 2017, 122, 997–1002. [Google Scholar] [CrossRef]
  42. Schaun, G.Z. The Maximal Oxygen Uptake Verification Phase: A Light at the End of the Tunnel? Sports Med.-Open 2017, 3, 44. [Google Scholar] [CrossRef] [Green Version]
  43. Krüger, M.; de Marees, M.; Dittmar, K.-H.; Sperlich, B.; Mester, J. Whole-Body Cryotherapy’s Enhancement of Acute Recovery of Running Performance in Well-Trained Athletes. Int. J. Sports Physiol. Perform. 2015, 10, 605–612. [Google Scholar] [CrossRef]
  44. Nitzsche, N.; Baumgärtel, L.; Schulz, H. Comparison of Maximum Lactate Formation Rates in Ergometer Sprint and Maximum Strength Loads. Dtsch. Z. Sportmed. 2018, 69, 13–17. [Google Scholar] [CrossRef]
  45. Quittmann, O.J.; Appelhans, D.; Abel, T.; Strüder, H.K. Evaluation of a Sport-Specific Field Test to Determine Maximal Lactate Accumulation Rate and Sprint Performance Parameters in Running. J. Sci. Med. Sport 2020, 23, 27–34. [Google Scholar] [CrossRef] [Green Version]
  46. Helgerud, J.; Støren, Ø.; Hoff, J. Are There Differences in Running Economy at Different Velocities for Well-Trained Distance Runners? Eur. J. Appl. Physiol. 2010, 108, 1099–1105. [Google Scholar] [CrossRef] [PubMed]
  47. Helgerud, J. Maximal Oxygen Uptake, Anaerobic Threshold and Running Economy in Women and Men with Similar Performances Level in Marathons. Eur. J. Appl. Physiol. Occup. Physiol. 1994, 68, 155–161. [Google Scholar] [CrossRef] [PubMed]
  48. Daniels, J.; Daniels, N. Running Economy of Elite Male and Elite Female Runners. Med. Sci. Sports Exerc. 1992, 24, 483–489. [Google Scholar] [CrossRef] [PubMed]
  49. Batliner, M.; Kipp, S.; Grabowski, A.; Kram, R.; Byrnes, W. Does Metabolic Rate Increase Linearly with Running Speed in All Distance Runners? Sports Med. Int. Open 2018, 2, E1–E8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. An exemplary description of the mathematical model for metabolic simulation, presenting the gross lactate formation (VLass) and the maximal lactate elimination rate (VLaoxmax) depending on exercise intensity [22]. Maximal lactate steady state (MLSS) is defined as the exercise intensity at which the lactate formation is exactly equal to elimination. VO2max = maximal oxygen uptake; VLamax = maximal lactate production rate; Ks4 = individual constant value of the relationship between oxygen demand and running velocity.
Figure 1. An exemplary description of the mathematical model for metabolic simulation, presenting the gross lactate formation (VLass) and the maximal lactate elimination rate (VLaoxmax) depending on exercise intensity [22]. Maximal lactate steady state (MLSS) is defined as the exercise intensity at which the lactate formation is exactly equal to elimination. VO2max = maximal oxygen uptake; VLamax = maximal lactate production rate; Ks4 = individual constant value of the relationship between oxygen demand and running velocity.
Medicina 57 01117 g001
Figure 2. An exemplary description of the determination of the individual Ks4 (constant value of the relationship between oxygen demand and running velocity). The slope of the regression line corresponds to Ks4. From this equation, Ks4 for this runner is 12.1 mL·kg−1·min−1 per 1 m·s−1.
Figure 2. An exemplary description of the determination of the individual Ks4 (constant value of the relationship between oxygen demand and running velocity). The slope of the regression line corresponds to Ks4. From this equation, Ks4 for this runner is 12.1 mL·kg−1·min−1 per 1 m·s−1.
Medicina 57 01117 g002
Figure 3. Bland–Altman Plots: differences in running velocity at calculated anaerobic lactate threshold (cLTAn) vs. modified maximal deviation method (mDmax; (a)) and onset of blood lactate accumulation (OBLA; (b)). The solid lines indicate the mean difference; the dotted lines indicate the limits of agreement (mean ± 1.96 SD); the dashed lines represent the fitted linear regression.
Figure 3. Bland–Altman Plots: differences in running velocity at calculated anaerobic lactate threshold (cLTAn) vs. modified maximal deviation method (mDmax; (a)) and onset of blood lactate accumulation (OBLA; (b)). The solid lines indicate the mean difference; the dotted lines indicate the limits of agreement (mean ± 1.96 SD); the dashed lines represent the fitted linear regression.
Medicina 57 01117 g003
Figure 4. Correlations (a) and intraclass correlation coefficients (b) of the running velocity at onset of blood lactate accumulation (OBLA), modified maximal deviation method (mDmax), and calculated anaerobic lactate threshold (cLTAn) compared to average running velocity over 3000 m (v3000), 5000 m (v5000), and 10,000 m (v10,000); * p < 0.05.
Figure 4. Correlations (a) and intraclass correlation coefficients (b) of the running velocity at onset of blood lactate accumulation (OBLA), modified maximal deviation method (mDmax), and calculated anaerobic lactate threshold (cLTAn) compared to average running velocity over 3000 m (v3000), 5000 m (v5000), and 10,000 m (v10,000); * p < 0.05.
Medicina 57 01117 g004
Table 1. Body mass, maximal oxygen uptake (VO2max), maximal lactate production rate (VLamax), constant value of the relationship between oxygen demand and running velocity (Ks4), and running velocity at the onset of blood lactate accumulation (OBLA), at the modified maximal deviation method (mDmax) and the calculated anaerobic lactate threshold (cLTAn) for each participant.
Table 1. Body mass, maximal oxygen uptake (VO2max), maximal lactate production rate (VLamax), constant value of the relationship between oxygen demand and running velocity (Ks4), and running velocity at the onset of blood lactate accumulation (OBLA), at the modified maximal deviation method (mDmax) and the calculated anaerobic lactate threshold (cLTAn) for each participant.
ParticipantBody Mass (kg)VO2max
(mL kg−1∙min−1)
VLamax
(mmol L−1 s−1)
Ks4
(mL kg−1∙min−1 per 1 m s−1)
OBLA
(m s−1)
mDmax
(m s−1)
cLTAn
(m s−1)
159.274.60.3812.15.194.934.70
264.470.00.3212.14.974.654.42
364.480.30.3313.2-5.124.87
472.668.00.3311.84.434.164.38
572.365.40.4211.34.544.434.20
668.562.30.4610.74.314.373.99
759.180.10.3114.24.534.334.53
873.267.40.5510.84.774.524.31
958.468.70.3311.04.944.614.72
1065.460.80.5011.04.133.973.66
Mean ± SD65.8 ± 5.869.8 ± 6.70.39 ± 0.0911.8 ± 1.14.65 ± 0.354.44 ± 0.28 *4.32 ± 0.34 *
* significantly different compared to OBLA (p < 0.01).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ji, S.; Sommer, A.; Bloch, W.; Wahl, P. Comparison and Performance Validation of Calculated and Established Anaerobic Lactate Thresholds in Running. Medicina 2021, 57, 1117. https://doi.org/10.3390/medicina57101117

AMA Style

Ji S, Sommer A, Bloch W, Wahl P. Comparison and Performance Validation of Calculated and Established Anaerobic Lactate Thresholds in Running. Medicina. 2021; 57(10):1117. https://doi.org/10.3390/medicina57101117

Chicago/Turabian Style

Ji, Sanghyeon, Aldo Sommer, Wilhelm Bloch, and Patrick Wahl. 2021. "Comparison and Performance Validation of Calculated and Established Anaerobic Lactate Thresholds in Running" Medicina 57, no. 10: 1117. https://doi.org/10.3390/medicina57101117

Article Metrics

Back to TopTop